Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Sorry Should have posted Chart

<< Previous

Bullboard Posts

Next >>

Comment by guerreiroon Dec 17, 2010 9:48pm

254 Views

Post# 17865157

RE: Sorry Should have posted Chart

Thanks for the chart Camaroni. It is evident that the market maker must keep the stock from running away as the (.50 cent) private placement has not closed yet and can not run away has the TSX approved at that price. Do not lose patience, someone is accumulating it; NB. Penson was buying at .60 at 15:19 and then at 15:56 just before the close, they sold at .55, .56. (I will just keep buying on pullbacks)
I realize that you are not knocking the company, but just trying to keep things in perspective. I still feel that something big is going behind the scenes. After all most of the stock is being held by strong hands. I am looking forward for the day that we have to buckle our seat belts on the way to $1, $2, $3. I am also willing to exchange HLO for HBM at the right price.

<< Previous

Bullboard Posts

Next >>

Revolutionizing medical imaging with nanocarbon-based contrast drugs